Kardigan
  • About Us
    • Purpose
    • Leadership
    • Partnering
    • Contact Us
  • Our Focus
    • Cardiac Intelligence
    • Clinical Pipeline
    • Genetic Dilated Cardiomyopathy
    • Calcific Aortic Valve Stenosis
    • Acute Severe Hypertension
    • Scientific Publications
    • Clinical Trials
  • Working Here
    • Kardigan Culture
    • Job Openings
  • Investors & Media
    • Overview
    • News & Events
      • News Releases
      • Events
      • Presentations
    • Stock Information
      • Stock Quote & Chart
      • Analyst Coverage
    • Corporate Governance
      • Documents & Charters
      • Management Team
      • Board of Directors
      • Committee Composition
    • Financial Information
      • SEC Filings
    • IR Resources
      • Investor FAQs
      • Email Alerts
      • Contact IR
  • Patients & Families
    • Patient Advocacy
Select Page

Efficacy of Tonlamarsen in Patients with Uncontrolled Hypertension: The KARDINAL Phase 2 Randomized Clinical Trial

by [email protected] | Mar 30, 2026 | Acute Severe Hypertension

  • About Us
  • Our Focus
  • Working Here
  • Investors & Media
  • Patients & Families
  • Linked In
  • Kardigan Privacy Policy
  • Terms of Use
  • Website by 22 Fillmore
© 2026 Kardigan. All rights reserved. KARDIGAN and the stylized K are trademarks of Kardigan, Inc.

This link will take you to a third party website. Kardigan is not commenting on or approving the accuracy of the information available on this third party website, and the company was not involved in the preparation of that information.

Back Continue